Innate Pharma SA
F:IDDA
Innate Pharma SA
F:IDDA
Price:
1.42
EUR
-4.05%
Market Closed
Market Cap:
€115m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
F:IDDA
|
FR |
|
McEwen Mining Inc
F:US8
|
CA |
|
P
|
Pentamaster Corporation Bhd
KLSE:PENTA
|
MY |
Wall St Price Targets
IDDA Price Targets Summary
Innate Pharma SA
Innate Pharma SA
Wall Street analysts forecast IDDA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IDDA is 4.99 EUR with a low forecast of 4.15 EUR and a high forecast of 5.95 EUR.
Lowest Forecast
Price Target
4.15
EUR
192% Upside
Average Forecast
Price Target
4.99
EUR
251% Upside
Highest Forecast
Price Target
5.95
EUR
319% Upside
Innate Pharma SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDDA's stock price target?
Price Target
4.99
EUR
4.99
EUR
According to Wall Street analysts, the average 1-year price target for IDDA is 4.99 EUR with a low forecast of 4.15 EUR and a high forecast of 5.95 EUR.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
92%
92%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 7 years is 92%.
